ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

BK Polyomavirus and Cytomegalovirus Infections in Kidney Transplantation from Hepatitis C Positive Donors to Uninfected Recipients

I. Yakubu, V. Amrutiya, I. Moinuddin, M. Levy, G. Gupta, A. Azhar

Virginia Commonwealth University, Richmond, VA

Meeting: 2022 American Transplant Congress

Abstract number: 258

Keywords: Cytomeglovirus, Hepatitis C, Kidney transplantation, Polyma virus

Topic: Clinical Science » Infection Disease » 26 - Kidney: Polyoma

Session Information

Session Name: Kidney: Polyoma Infections

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 6, 2022

Session Time: 3:30pm-5:00pm

 Presentation Time: 4:30pm-4:40pm

Location: Hynes Room 309

*Purpose: Transplantation of hepatitis C viremic (HCV) donor kidneys into uninfected recipients (D+/R-) is becoming more common in the United States. However, the long-term risks associated with HCV viremic) donor transplants are still unknown. Recent ‘transmit-and-treat’ studies have suggested that donor HCV might be associated with an increased risk of BK polyomavirus (BKPyV) and CMV infections. It has been suggested that this may be due to the suppression of host immune response due to HCV. We have previously reported a HCV transmission rate of only 9% with an ultra-short pangenotypic DAA prophylaxis of 2- 7days. Here we report the incidence of BKPyV and cytomegalovirus (CMV) infections in this cohort and compare these rates with a matched cohort (1:1 fashion) of HCV D-/R- KTR.

*Methods: All patients received induction with rabbit anti-thymocyte globulin followed by triple immunosuppression with tacrolimus, mycophenolate and prednisone. D-/R- KTR in our center (controls) were matched with cases (D+/R-) in a 1:1 distribution based upon the following: a) transplant time period in the post-kidney allocation system (KAS) era (January 2015 onwards), b) ‘kidney-only’ transplant with ≤1 previous organ transplant, c) pre-transplant diabetes, d) EPTS score category measured in quintiles (0-20%, 21-40%, 41-60%, 61-80%, 81-100%) d) cPRA at transplant <50%; e) negative crossmatch at transplant; and f) DSA at transplant≤3000 MFI.

*Results: A total of 102 D+/R- transplants (mean age=52) were included with the following distribution; Group 1 (2-4d prophylaxis; N=52) and Group 2 (7d prophylaxis; N=50). Of the 9 patients that developed viremia, all patients achieved sustained virologic response post-full course therapy. Controls (N=102; D-/R-) were more likely to be African-American (73% vs 59%; p=0.04), have pre-formed donor specific antibodies at transplant (13% vs 3%, p=0.02) and have higher KDPI (mean 66 vs 56, p=0.001) compared with D+/R- recipients. The two groups were well-matched with other aforementioned matching criteria including CMV donor-recipient seromismatch. Recipients of HCV D+/R- had equivalent CMV infection (14% vs 14%, p=1.0) but less CMV disease compared to controls (71% vs 29%, p=0.05) amongst those who developed viremia. There was a numerically higher incident risk of any BKPyV infection (20% vs 12%, p=0.12), and high plasma titer BKPyV ≥10000 (12% vs 6%, p=0.21) in the D+/R- group compared with D-/R- group that did not reach statistical significance.

*Conclusions: In this large single-center study of HCV NAT+ transplants, we did not find an increased risk of CMV infections. There was a numerical trend for increased BKPyV that was seen predominantly in patients without HCV replication. These data suggest one of two possibilities: One, lack of HCV replication may be protective against CMV; or two, that the apparent increased risk of opportunistic viral infections may be due to unmeasured confounders in patient selection.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Yakubu I, Amrutiya V, Moinuddin I, Levy M, Gupta G, Azhar A. BK Polyomavirus and Cytomegalovirus Infections in Kidney Transplantation from Hepatitis C Positive Donors to Uninfected Recipients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/bk-polyomavirus-and-cytomegalovirus-infections-in-kidney-transplantation-from-hepatitis-c-positive-donors-to-uninfected-recipients/. Accessed May 31, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences